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1. Introduction. – In 2007, Leitgeb et al. [1] presented a historical overview 
about research on alamethicin (ALM), discussing the discovery, primary structure, 
biosynthetic pathway, structural and conformational properties, channel formation 
and biological activities of ALM and its synthetic analogues.  
ALM is a linear peptide belonging to the family of peptaibols. ALM consists 
of 20 amino acid residues with phenylalaninol (Pheol) at the C-terminus and an 
acetylated N-terminus. The originally described compound is composed of two major 
groups named ALM F30 and ALM F50 and a minor component (ALM F20) based 
on their retention factor values in tissue liquid chromatography on acidic silica gel 
[2]. 
The organism producing ALM – originally named as compound U-22324 – 
was initially reported to be ’Trichoderma viride’ strain NRRL 3199 [3]. However, 
the producer was recently reidentified as T. arundinaceum from the so-
called ”Brevicompactum clade” of the genus Trichoderma [4]. Furthermore, all other 
Trichoderma species known to produce ALM (T. brevicompactum, T. protrudens, T. 
turrialbense) also belong to this clade [5] [6]. 
Biosynthesis of ALM is independent from the general, ribosomal peptide-
translation pathway. Similarly to all other peptaibols, ALM is synthesized in a 
microheterogenous mixture on a multi-enzyme complex from the family of 
nonribosomal peptide synthetases (NRPSs), that are large multifunctional enzymes 
with modular structure, assembling the peptides using a protein template via the 
multiple-carrier thiotemplate mechanism [7]. Most of the NRPSs terminate peptide 
synthesis with the thioesterase domain, which is however, missing from the peptaibol 
synthetase of Trichoderma virens (TPS). Manavalan et al. [8] presented a three-
dimensional (3D) model of the reductase domain of TPS, which is playing a role in 
the release of the mature peptide products reductively with the aid of a NADPH 
cofactor. The authors identified the binding sites of the probable linear substrates 
including ALM, antiamoebin I, chrysopermin C, gramicidin and trichotoxin within 
the modeled reductase domain using multiple docking approaches. 
As summarized by Leitgeb et al. [1], ALM has a predominantly α-helical 
conformation with a small distortion in the structure generated by the Pro residue at 
the 14th position, which is referred to as proline-kinked α-helical conformation. ALM 
is capable of binding to the surface of lipid bilayers and insertion into the membranes, 
which is depending on a series of parameters like elasticity, structure and hydration 
level of the lipid bilayer, peptide concentration, peptide/lipid molar ratio as well as 
temperature [1]. The channel structures formed by ALM and its analogues were 
examined and the residues important for ALM-bilayer interactions, channel 
formation and channel stabilization could be identified. Molecular modeling studies 
of ALM bundles embedded in lipid bilayers revealed important data about the 
structural and dynamic features of ALM [1]. 
The wide spectrum of biological activities exhibited by ALM includes 
antimicrobial effects, elicitation of systemic plant-defense responses, tissue damage 
in insect larvae as well as cytolytic activity towards mammalian cells [1]. 
The aim of this review is to summarize the significant amount of information 
about ALM which accumulated in the literature during the past 5 years since the 
publication of the review of Leitgeb et al. [1]. 
 
2. Recent Results about Alamethicin-Membrane Interactions − ALM is 
perhaps the most studied pore-forming antimicrobial peptide (AMP), which is 
primarily due to its use as a model of voltage-gated ion-channel conduction. It can 
bind to the surface of different lipid bilayers, and after that it can insert into them 
with multiple open states regarding to its oligomerization level. The dependence of 
this process from several parameters such as temperature, peptide concentration, 
peptide/lipid (P/L) molar ratio and the type of the lipid bilayer was described and 
reviewed in details by Duclohier and Wróblewski [9]. The present review will focus 
on recent results about ALM-membrane interactions summarizing the novel 
experimental setups in bilayer techniques, pore modulation and regulation 
possibilities, features of the lipid bilayer environment of pores as well as biosensing 
opportunities. ALM is applied these days as an “etalon” or control in several cases 
for the characterization of conduction features of novel pore-forming molecules 
[10−12]. Its fusogenic effect was also tested on lipid vesicles as one of the gold 
standards of membrane activity, but it was completely inactive in the applied 
experimental setup [13].  
2.1. Experimental Designs to Test Pore Formation of Alamethicin. In the case of 
traditional black lipid membranes (BLMs), the lipids are associated solely via 
relatively weak intermolecular interactions. Therefore their lifetimes are significantly 
limited and long-term monitoring of ALM ion channel activity as well as effective 
involvement in biosensing applications is not possible. There are some strategies to 
prolong the lifetime of the membrane test systems including polymerization, 
hydrogel support and miniaturized apertures. Heitz et al. [14] described mixed BLMs 
prepared using bis-dienoyl phosphatidylcholine and diphytanoyl phosphatidylcholine, 
which exhibit greatly enhanced stability upon photopolymerization (4 days) relative 
to unpolymerized BLMs (4 hours). In this experimental setup, ALM − for which a 
relatively high membrane fluidity is required − could maintain its pore forming 
activity and showed a characteristic series of its subconductance states, but higher 
currents were measured on it due to increases in size, number and/or frequency of 
pores [14]. The other strategy for the extension of membrane lifetime is the 
maintenance of the solvent annulus at the aperture boundary. For this purpose, Jeon 
et al. [15] explored ways by encapsulating and conjugating the BLM within 
hydrogels and formed it on a glass substrate. Using this approach, continuous 
electrical and optical monitoring of membranes was achieved for 12 days. ALM was 
able to successfully incorporate into these types of membranes and the measured 
channel conductances were similar to those measured prior to polymerization as well 
as in conventionally formed membranes. Harriss et al. [16] developed a new method 
for the generation of artificial lipid bilayers, which involves contacting the 
monolayers formed on a nanoliter aqueous droplet and a hydrogel layer immersed in 
an oil/lipid solution to create a bilayer. This method enables both single-molecule 
fluorescence Ca2+ flux imaging and single-channel electrical recording from the 
bilayer. This simultaneous measurement allowed observation of multiple 
conductance steps originating from a single ALM pore. The individual pores switch 
rapidly between distinct conductance states which correlated with fluorescent 
measurements, confirming that multiple conductance states could be originated even 
from a single pore. Maurer at al. [17] brought together several previously developed 
features into a single microfabricated structure, creating large-sized orifices on 
silicon nitride substrates in combination with an agarose backing layer. The created 
membrane system showed enhanced stability (4 days) and was appropriate for the 
measurement of single channel conductance and sub-conductance states of ALM at 
levels similar to that observed in a vertical painted BLM. The presence of automated 
laboratory instruments in the research work can also help in the formation of lipid 
bilayer systems through a „hand-free” way [18]. Using an automated liquid-handling 
equipment, a lipid membrane platform was developed, which can allow the high 
throughput measurement of a large number of different samples simultaneously by 
adopting a vertical orientation of the monolayer contacting method. The platform 
was succesfully tested for ALM membrane pores and it was suggested as an 
excellent tool for the high throughput ion channel drug screening.  
Krauson et al. [19] designed a novel set of analytical tools, which allow to 
examine the pore properties of ALM using fluorescent head group-labeled lysolipid 
monomers. This test system represents other approach than the conductance 
recordings and is able to measure four properties of peptides at very low peptide to 
lipid ratio. These properties are the following: i) the potency of peptide pores, ii) the 
continued presence or absence of peptide pores at equilibrium, iii) intermembrane 
exchangeability of pore-forming peptides, and iv) disrupting effect at equlibrum. 
Theoretically, 4–20 peptides (1–2 pores) were the lowest detection limit of the 
described technique.  
2.2. Pore Modulation Effects. Artificial lipid membranes (mainly the BLMs) 
have been widely used to reconstitute and study ALM channels, as they allow 
electrochemical access to both sides of the ion channel-membrane complex, where 
multiple single-channel conductance levels can be recorded, which reflect uptake and 
release of individual monomers within trans-membrane conducting bundles [20]. 
The pH can also play an important role in modulation of electric features of 
zwitterionic-based artificial lipid membranes. This pH effect on transmembrane 
electrical properties of membranes was examined in the work of Chiriac and Luchian 
[21] by evaluating the transport properties of embedded ALM oligomers over a wide 
range of pH values. Their investigation involved single ALM oligomers, and they 
demonstrated an unexpected, non-monotonic dependence of the single channel 
electrical conductance in the function of pH. At extreme acidic values, the electrical 
conductance of the first and the second sub-conductive state of the ALM oligomer is 
reduced with about 20% and 11%, respectively, as compared to moderately acidic 
pH values. The proposed mechanism is that the partitioning of hydrogen and 
hydroxide ions between both membrane sides leads to changes of the overall 
superficial charge on the membrane and of the membrane dipole potentials, allowing 
modulation of the local concentration of cations near the ALM oligomer, thereby 
facilitating their hopping across the channel. Additionally, pH modulation has an 
effect among lipid head groups of membrane monomers, which could alter the 
curvature stress in the bilayer, and this would lead to a visible mechanical 
constriction of the ALM pore manifested by a drop in its conductance at moderated 
pH values [22] [23]. Amphiphilic compounds can provide reliable tools to 
understand the effects of asymmetry in the electrostatic features of a reconstituted 
lipid membrane on the dynamic properties of ALM. They preferentially partition into 
a single membrane leaflet, added vectorially to the membrane opposite to the side of 
ALM insertion to controllably alter the dipole and surface potential and provide a 
quantitative evaluation of the effects of asymmetric bilayer electric potentials on 
peptide function. The styrylpyridinium dye RH 421 absorbs on the lipid bilayer 
interfacially and increases the membrane dipole potential, which could decrease the 
membrane activity of ALM most likely via an elevated repelling influence upon the 
positively charged N-terminus, as it moves across the interfacial region and 
penetrates the lipid membranes [24]. Other amphiphiles like phlorizin and sodium 
dodecyl sulfate partition also preferentially into a single membrane leaflet, when 
added vectorially to the membrane opposite to the side of ALM insertion to 
controllably alter the dipole and surface potential. It was described that these 
potentials generated asymmetry between the both sides of a membrane and give a 
trans-bilayer driving force, which strongly modulates the ALM activity and ion 
transport properties. Specifically, phlorizin (a dipole potential lowering agent) 
augmented the ALM activity, while in the case of RH-421 the opposite was observed 
because of the membrane dipole potential enhancing effect of the amphiphile. The 
ion conductance of oligomeric ALM in its various substates is increased and 
decreased by the injection of phlorizin and RH-421, respectively on the trans sub-
phase in the same manner. Additionally, after termination of electric modulatory 
effects through the membrane bilayer applying the anionic detergent sodium dodecyl 
sulfate on both sides of the membrane, its mechanical effect on peptide activity 
remained still active [25]. 
Aliverdieva et al. [26] studied the initial steps of pore formation in rat liver 
mitochondria preparations as a potassium transmembrane current sensor generating 
transmembrane potential to evaluate the molecularity of the rate-limiting step of pore 
formation by ALM in situ. The applied transmembrane current depends linearly on 
the degree of steady-state activation of the model membrane respiration. This 
activation was limited by association of monomers of ALM to pre-pore and the order 
values coincided with molecularity or the degree of pre-pore oligomerization, and it 
was close to 2 formed by ‘‘dimers’’. Vedovato and Rispoli [27] applied a novel 
technique to study ALM under strict physiological conditions, which consisted of 
inserting the peptides into cell plasma membranes where all the endogenous current 
sources were blocked. During the conductance measurements the general single-
channel events were recorded at low ALM concentrations (<250 nM) according to 
the different number of helices constituting a single channel. However, after four-
fold reduction of peptaibol concentration, the current fell from several hundreds of 
pA to the single channel level and after the removal of ALM it fell to zero within a 
few hundred ms, which shows the cooperativity and fast speed of disaggregation. 
2.3. Size of Alamethicin Pores and the Effect of Lipid Environment on Pore 
Formation. Katsu et al. [28] applied calcein as fluorescence permeability marker 
simultaneously with K+ release measurement to study the ALM permeability in 
liposomes. This technique can provide significant information about the sizes of 
pores based on the differences in the rates of release of K+ and calcein, although their 
results were confirmed also by conducting an osmotic protection experiment. They 
found that amphiphilic peptides, including ALM, formed relatively large pores 
(belonging to the type 3 cluster) in liposomal membranes (>0.67 nm radius) and did 
not form small above-mentioned voltage-gated ion-channels in the applied liposomal 
membrane. ALM-induced holes were directly visualized in gel 
dipalmitoylphosphatidylcholine membranes by atomic force microscopy and both the 
structure of pores and the membrane around the transmembrane peptides were 
characterized [29]. According to the calculation of pore perimeters it was observed 
that at the lower ALM concentration (1 mol%) the number of aggregated peptaibol 
molecules varied from 30 to 300 molecules per hole, while at the higher 
contcentration of 4 mol% it reached a value of up to 1200. These detected pores were 
referred as ‘defects’ because of their relatively large diameter, although they may be 
closely related to, or indistinguishable from pores. Furthermore, lipid membrane 
phase behaviour was altered in the vicinity of these defects determined by 
differential scanning calorimetry [29]. This phenomenon was induced by ALM 
molecules, which influence the heat capacity profiles of membranes perhaps through 
the distribution of lipids with different state or chemical nature affecting the elastic 
constants in the pore environment to bring the membrane system close to a melting 
transition. It was concluded that in native biological membranes this process could 
play an important role in controlling the physical features of lipid–protein complexes 
[30]. This membrane alteration effect was also observed using dilatometry and small-
angle X-ray diffraction of dioleoyl phosphatidylcholine bilayers, which manifested in 
the form of membrane thinning, increase to the lateral area per lipid and a decrease in 
the bending rigidity of the membranes. Moreover, it was suggested that softening of 
the lipid bilayer significantly influences lipid-mediated peptide-peptide interactions 
in the pore formation [31]. The importance of the lipid-peptide interaction and of the 
chemical nature was also demonstrated during the examination of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine liposomes by cryo-transmission electron 
microscopy in combination with turbidity and leakage measurements, where it was 
proved that cholesterol modulates the membrane perturbing effect of ALM [32]. The 
ALM concentrations induced membrane rupture and fusion of cholesterol-
supplemented liposomes, but did not cause any discernible structural alterations in 
systems containing cholesterol-free liposomes. Bertelsen et al. [33] also reinforced 
the importance of the full system in structural studies of membrane peptides due to 
the effects of the peptid-lipid interactions. They concluded that especially the fold 
and possibly the oligomerization of ALM may be altered if ether lipids are used 
instead of the naturally occurring ester lipids in artificial lipid system. 
2.4. Practical applications. Based on the accumulated knowledge about the 
pore forming properties and the regulation possibilities of the assembled channels it 
is possible to integrate this biological construction into biotechnological and 
biosensing appications. Mayer et al. [34] described the use of a synthetically 
modified ALM in planar lipid bilayers to quantify protein-ligand interactions. The 
technique is based on the measurement of ion flux, which appears as reduced 
conductivity through the pores where the monomers contain covalently attached 
benzenesulfonamide group on the C-terminus. The linked group is a substrate of the 
carbonic anhydrase II enzyme and after the protein-ligand interaction it triggers the 
reduction of the ion current between the two sides of the membrane at a measurable 
level. If the recorded currents were time-averaged, the amount of transported charge 
before and after the addition of the enzyme was distinguishable to serve a promising 
amplifying method for sensing enzymatic reactions like the widely applied enzyme-
linked immunosorbent assay (ELISA). Bionanoelectronic interfaces involve 
functional integration of nanomaterials with membrane proteins and peptides, and 
ALM-oligomerized pores are potential candidates for this purpose. A novel 
construction was published using silicone nanowire transistor, which contains 
nanowire covered by lipid membrane-incorporated ALM molecules [35]. This 
membrane-shielded wire setup was able to enable and control ionic to electronic 
signal transduction by using voltage-gated and chemically-gated ion transport 
through the membrane pores. The constructors of the device exploited that at 
negative membrane potentials ALM does not span the entire transmembrane 
thickness, while at positive membrane potentials it penetrates the membrane 
completely and forms a channel, which allows the opening and closing of the pores 
in the lipid bilayer like turning on and off a simple electrical switch. Furthermore, the 
closing state of the pores was completely identical with the ALM-free bilayer-coated 
nanowire design. Besides the electronic control, the ALM pores are able to actuate 
also with mechanical effect according to the interaction between the lateral pressure 
profile and the ALM pore formation [36]. A laser-drilled, single-crystal quartz 
substrate was used efficiently as a mechanotransductive interface to influence the 
diameter of the ALM pores by exciting opposing thickness-shear modes [37]. The 
increased mechanical effects on the lipid membrane increased the larger conductance 
states of the incorporated channels: the mechanical tension changes were able to 
transduce into an electrical signal response, thereby serving a new way for the 
utilization of the piezoelectric-based membrane system as a mechano-sensitive 
biosensors.  
Kropacheva and Raap [38] reported the biotechnological application of 
ALM-membrane system for improving the bilayer-separated enzyme reactions using 
a new strategy for increasing the substrate permeability through membrane bilayers. 
They studied the enzymatic hydrolysis of Na-benzoyl-l-arginine-p-nitroanilide 
hydrochloride by liposome-encapsulated trypsin. The substrate which was applied at 
the outer side of the membrane showed low permeability on the liposome. In this 
model system, approximately seven-fold increase of the enzymatic reaction rate was 
observed in the presence of the peptaibol, when compared with the control where the 
peptaibol molecules were not added to the liposomes. These results suggest that 
ALM could be used in reactions catalyzed by vesicle- or cell-entrapped enzymes as a 
substrate carrying agent. 
 
3. Recent Results about Structural and Conformational Properties of 
Alamethicins and their Channels. − The review of Leitgeb et al. [1] discussed 
previous results about the 3D structure and the different conformational features of 
ALM and its analogues, derived from a variety of experimental techniques, including 
X-ray diffraction (XRD), Nuclear Magnetic Resonance (NMR), Circular Dichroism 
(CD), Raman and Fourier Transform Infrared (FTIR) spectroscopies, as well as 
obtained by various theoretical methods, comprising distance geometry (DG), 
simulated annealing (SA) and molecular dynamics (MD). The earlier experimental 
and theoretical studies were performed in different environments under various 
circumstances, i.e. in the crystalline phase, in aqueous solution, in several organic 
solvents, in the presence of various micelles as well as in different membranes. As 
summarized by Leitgeb et al. [1], the structural investigations of ALM channels and 
ALM-analogue channels were predominantly carried out using different MD 
simulations. The present review is discussing the recent developments in this field. 
3.1. X-Ray Diffraction Studies. Crisma et al. [39] examined the 3D structure 
of a spin-labeled ALM analogue ([TOAC16,Glu(OMe)7,18,19] ALM F50/5, Table 1) 
by means of XRD, and two individual molecules were identified. Both of them could 
be characterized by a bent, predominantly α-helical conformation, however, they 
showed differences with regard to their intramolecular H-bonding patterns, as well as 
to their bend angles detected near the Pro14 amino acid. For the helical structures of 
two molecules, the side-chains of three γ-methyl glutamate (Glu(OMe)) residues 
were found on the same side, whereas the most hydrophobic side-chains and the 
2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC) residues 
were located on the opposite side, resulting in a hydrophilic convex as well as a 
hydrophobic concave face of both peptides. Based on the results it was concluded 
that the overall conformational features of two crystallographically independent 
molecules were found to be similar to those observed previously for the three 
individual ALM molecules identified in the asymmetric unit cell of crystals [40]. 
In the XRD study performed by Qian et al. [41], the electron density profile 
of transmembrane pore induced by the ALM molecules was reconstructed, applying 
fully hydrated multiple bilayers of the ALM-lipid mixtures. The results derived from 
this XRD measurement pointed out unequivocally that the structure of ALM-induced 
pore corresponded with the “barrel-stave” model composed of eight ALM helices. In 
the course of this study, the ALM pore was directly imaged for the first time by 
reconstructing the electron density of pore on the basis of XRD measurement. 
3.2. Spectroscopic Studies. Salnikov et al. [42] investigated the structural 
features of ALM F50/7 by 15N and 31P solid-state NMR spectroscopy, with regard to 
its membrane-bound state, applying two types of lipid bilayers, i.e. 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) membranes. As the NMR data indicated, the structure of 
ALM inserted into the lipid bilayers was characterized by a mixed α-/310-helical 
conformation. Nevertheless, this NMR study led to the observation that ALM 
adopted a more tilted helical structure for the DMPC membrane as compared to that 
determined for the POPC membrane. 
The membrane-bound conformation of ALM F30/3 was examined by Bertelsen 
et al. [43], using 2H Magic-Angle Spinning (MAS) solid-state NMR spectroscopy, 
and it was assumed that ALM adopted an α-helical structure. In this study it was 
demonstrated that 2H MAS NMR experiments could be applied as a novel method to 
obtain fast and accurate conformational constraints concerning the peptaibol 
molecules in their membrane-bound environments. In a subsequent study, Bertelsen 
et al. [44] applied 1H-15N and 2H solid-state NMR spectroscopy in order to derive 
residue-specific information about the conformational dynamics of ALM F30. Based 
on the NMR data, detailed information was provided with regard to the tilt angle of 
helix, to wobbling, as well as to the oscillatory rotation around the helix axis for the 
membrane-bound conformation of ALM. Comparing the results obtained by this 
NMR study with those derived from the coarse-grained (CG) MD simulation 
performed on ALM molecules [45] it was concluded that the experimental and 
theoretical data concerning the dynamic model were in good agreement with each 
other. In a more recent study, the interplays between ALM F30 and ether/ester 
phosphocholine lipid bilayers were investigated by Bertelsen et al. [33] using CD 
spectroscopy to determine the secondary structure of ALM, as well as applying 
oriented solid-state NMR spectroscopy to characterize the conformational and 
dynamic features of the peptide in detail. As the results indicated for ALM, 
differences were observed with regard to the secondary structure as well as to the 
temperature-dependent membrane anchoring, taking into account the two types of 
lipid bilayers. The CD spectra revealed that ALM did not adopt a predominantly α-
helical conformation either in ether bicelles or in ester bicelles, and based on this 
observation it was suggested that the lipid environments affected the structural and 
conformational properties of membrane-bound ALM. 
Kouzayha et al. [46] studied the interactions of ALM with Langmuir monolayers 
and multilamellar vesicles by IR and NMR spectroscopies in order to identify the 
role of peptide conformation played in the interplays evolved between ALM and 
lipids. At the air-water interface it was observed that ALM could be characterized by 
an α-helical structure, and the α-helix axis of the ALM peptide was preferentially 
oriented parallel to the air-water interface. Studying the interactions of ALM with 
DMPC and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) monolayers 
led to the observations that for the DMPC monolayers the ALM-ALM interactions 
were more stable than the interplays between the peptide and lipid, whereas for the 
DPPC monolayers the DPPC-ALM interactions were found to be more stable as 
compared to the interplays observed between the ALM peptides. The results obtained 
by IR and NMR measurements indicated that the ALM interacted with the DMPC 
multilamellar vesicles via hydrophobic interactions with alkyl chains. 
Ye et al. [47] applied Sum Frequency Generation (SFG) vibrational spectroscopy 
and Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-
FTIR), to characterize the interplays between ALM and various lipid bilayers 
without the presence of a membrane potential. The results revealed that different 
peptide-lipid interactions could be observed for the fluid-phase lipid bilayers, in 
comparison with those found for the gel-phase ones. In fluid-phase lipid bilayers, 
ALM was characterized by a mixed α-/310-helical conformation, and its N-terminal 
helical part was found to be more tilted than its C-terminal helical part, with respect 
to the surface normal. In contrast, ALM molecules could not insert significantly into 
the gel-phase lipid bilayers, however, they lay down and/or aggregated on the surface 
of this type of lipid bilayers. In a subsequent study, Ye et al. [48] investigated the 
interactions between ALM and POPC lipid bilayers in the presence of a membrane 
potential, using SFG vibrational and ATR-FTIR spectroscopies. For ALM molecules, 
the orientation in POPC lipid bilayers was determined at different pH values, where 
the tilt angles were calculated in the case of N-terminal α-helical part, as well as of 
C-terminal 310-helical part, respectively. Based on the results it was observed that the 
values of tilt angles were decreased as a function of the increasing pH values. Overall 
it was concluded that the change in the membrane potential modulated by the 
alteration of pH values produced an effect not only on the orientation of peptide, but 
also on the bend measured between two helical segments. 
Stella et al. [49] synthesized a set of ALM F50/5 analogues and they examined 
the position and orientation of these peptides in the membrane environment by ATR-
FTIR measurements. For two of these analogs ([Glu(OMe)18,19] ALM F50/5 and 
[Glu(OMe)7,18,19] ALM F50/5, Table 1), two and three Gln amino acids were 
substituted by Glu(OMe) residues, respectively. For the other two ALM analogues 
(Fmc-[Glu(OMe)7,18,19] ALM F50/5 and [Glu(OMe)7,18,19] ALM F50/5-Fmc, Table 1), 
relative to the [Glu(OMe)7,18,19] ALM F50/5, a 9H-fluoren-9-ylacetyl (Fmc) group 
was introduced either at the N-terminal end or at the C-terminal end of the peptide. 
This ATR-FTIR study demonstrated that the N-terminal part of peptides was inserted 
into the membrane, while their C-terminal part was found to be exposed to the outer 
aqueous phase, and furthermore, different orientations of molecules were observed 
with respect to the normal of membrane. For the ALM F50/5 and its analogues the 
CD spectra proved to be almost identical, indicating that the sequence modifications 
of parent peptide did not affect the helical structure and the conformational features 
of ALM F50/5. 
Peggion et al. [50] performed a detailed conformational analysis in solution by 
means of CD, FTIR and NMR spectroscopies for the [Glu(OMe)7,18,19] ALM F50/5 
analogue (Table 1) and for its four derivatives containing TOAC residues instead of 
Aib amino acids ([TOAC1,Glu(OMe)7,18,19] ALM F50/5, [TOAC8,Glu(OMe)7,18,19] 
ALM F50/5, [TOAC16,Glu(OMe)7,18,19] ALM F50/5 and [TOAC1,16,Glu(OMe)7,18,19] 
ALM F50/5, Table 1). The CD spectra of five ALM analogs were found to be very 
similar to that observed for ALM, indicating that these peptides adopted a highly 
helical conformation, containing a large amount of α-helix, as well as a small 
amount of 310-helix. Based on the data derived from the FTIR measurements it was 
concluded that the preferred conformation of peptides could be characterized by a 
highly folded structure, which was stabilized by intramolecular H-bonds. The NMR 
study carried out on the [Glu(OMe)7,18,19] ALM F50/5 analogue revealed also that 
this peptide was largely helical. Overall, the afore-mentioned spectroscopic studies 
led to the conclusion that neither the Gln vs. Glu(OMe) nor the Aib vs. TOAC 
replacements produced any significant effects on the preferred conformation of the 
parent peptide, ALM. 
The self-aggregation of a spin-labeled ALM F50/5 analogue 
([TOAC16,Glu(OMe)7,18,19] ALM F50/5, Table 1) in egg phosphocholine (ePC) 
vesicles was studied by Milov et al. [51], applying the Pulsed Electron-Electron 
Double-Resonance (PELDOR) technique. The data derived from this experiment 
pointed out that the ALM analogue self-aggregated in ePC vesicles, and this 
aggregates consisted of about four peptides. In this study it was demonstrated that the 
PELDOR method could be applied to determine long-range distances between 
transmembrane helical peptides. Subsequently, Milov et al. [52] used the PELDOR 
technique, to characterize the conformation of a further spin-labeled ALM F50/5 
analogue ([TOAC1,16,Glu(OMe)7,18,19] ALM F50/5, Table 1) for the non-aggregated 
peptides in pure ePC and in solvents with various polarity, as well as for the 
aggregates of peptides in hydrated ePC vesicles. The results pointed out that the 
intramolecular distances between the two TOAC residues were in excellent 
agreement with that calculated based on the α-helical conformation of this ALM 
analogue. Furthermore it was concluded that the above-mentioned distances are 
independent of the applied experimental conditions, namely, they depended neither 
on the aggregated state of the peptide nor on the polarity of the solvent. Overall, the 
data obtained by the PELDOR spectroscopy indicated that this spin-labeled ALM 
analogue could be characterized by a predominantly α-helical conformation. 
Additionally, for the aggregated peptides it was observed that the hydrophilic 
residues were located on the same side of the α-helical structure, resulting in an 
amphipathic character of aggregated molecules. Jose et al. [53] determined nitroxide 
to peptide NH proton distances derived from Paramagnetic Relaxation Enhancement 
(PRE) measurements for [TOAC1,Glu(OMe)7,18,19] ALM (Table 1), which were 
compared with the intramolecular distances obtained by the previously-mentioned 
XRD study performed on [TOAC16,Glu(OMe)7,18,19] ALM F50/5 [39]. The results 
led to the conclusion that the distances identified via PRE measurements were in 
close agreement with those obtained from the XRD-based model, indicating that the 
conformational properties of these ALM analogues were similar to each other in 
solution and in the crystalline phase. Additionally, it was suggested that these 
structural information regarding the intramolecular distances could be applied as 
long-range distance restraints in the case of NMR-based structure determination. 
Maisch et al. [54] synthesized a series of ALM analogues (Table 1), in which 
the Aib amino acids located in positions 5, 10 and 16 were substituted either by the 
(R)- or by the (S)-stereoisomer of trifluoromethylalanine (CF3-Ala) residues, 
respectively, resulting in six different analogues of the parent peptide. The structural 
features of these ALM analogues − regarding their conformation, alignment and 
dynamics − were examined by solid-state 19F NMR spectroscopy in DMPC bilayers. 
For ALM and its six analogues, the CD measurements performed in solution 
revealed similar spectra, indicating that these peptides could be characterized by a 
high helical content, as well as pointing out that the replacement of Aib amino acids 
by the CF3-Ala residues did not perturb the backbone conformation of ALM 
analogues. On the basis of the results it was concluded that the N-terminal part of 
ALM adopted an α-helical conformation, which showed a transmembrane alignment 
with a characteristic tilt angle in DMPC membranes. 
The structural properties of another set of ALM analogues were investigated by 
Noshiro et al. [55] using CD spectroscopy in the presence of POPC vesicles. For the 
parent ALM analogue (HG-ALM, Table 1) a His residue was attached via a Gly 
spacer at the N-terminal end of the ALM sequence, while for its three derivatives 
HG-[Leu]ALM, HG-[Nva]ALM and HG-[Nle]ALM (Table 1) all the Aib amino 
acids were substituted by Leu, norvaline (Nva) and norleucine (Nle) residues, 
respectively. In the case of all four peptides, the CD spectra indicated a helical 
structure in the absence of Zn2+, however, it was observed that the addition of Zn2+ 
caused changes for HG-ALM and HG-[Nva]ALM, while did not cause significant 
changes for HG-[Leu]ALM and HG-[Nle]ALM, regarding their CD spectra. Based 
on these results the helical contents of the latter two peptides were found to be 
similar to those found for the former ones, but in the case of HG-ALM and HG-
[Nva]ALM, a significant enhancement of helical conformations was detected in the 
presence of Zn2+. 
Hjorringgaard et al. [56] synthesized a new class of templated ALMs, for 
which the peptides were conjugated to the α- and β-cyclodextrins either from the N-
terminal end or from the C-terminal end. On the basis of CD spectra it was observed 
that the secondary structure adopted in solution was similar for these ALM:CD 
conjugates to that found in lipid, nevertheless, the membrane-induced structure of 
templated ALMs proved to be the same as that of ALM. In order to determine the 
orientation of peptides in lipid, Oriented Circular Dichroism (OCD) measurements 
were performed. The results indicated a more tilted state of α-helices for the N-
terminally linked ALM conjugates (ALMNαCD and ALMNβCD), while 
perpendicular helices were observed for the C-terminally linked ALM conjugates 
(ALMCαCD and ALMCβCD) as well as for ALM. 
3.3. Combined Spectroscopic and Theoretical Studies. Dittmer et al. [57] 
studied the incorporation and the membrane-bound conformation of ALM in lipid 
bilayers by means of 1H liquid-state NMR spectroscopy combined with MD 
simulations, applying 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine/1,2-
dihexanoyl-sn-glycero-3-phosphatidylcho-line (DMPC/DHPC) bicelles. Based on 
the distance restraints derived from the Nuclear Overhauser Effect (NOE) and PRE it 
was observed that the structure of ALM in the bilayers could not be characterized by 
a single conformational model because of the dynamics and heterogeneity of 
investigated system. These NOE and PRE data were then compared with the results 
obtained by MD simulations performed on an ensemble of ALM peptides in DMPC 
bilayer. Overall it was concluded that the combination of NMR spectroscopy and 
MD simulations provided more information about the flexibility of ALM in the 
membrane environment as well as of ALM-lipid interactions. 
For three spin-labeled ALM analogues ([TOAC1,Glu(OMe)7,18,19] ALM 
F50/5, [TOAC8,Glu(OMe)7,18,19] ALM F50/5 and [TOAC16,Glu(OMe)7,18,19] ALM 
F50/5, Table 1), Electron-Spin-Resonance (ESR) and PELDOR measurements were 
carried out by Milov et al. [58] in various solvents in order to study the self-assembly 
of helical peptides. According to the different polarity of solvents, the ALM 
analogues showed distinct characteristics concerning their self-assembly behavior, 
namely, the peptides formed homogeneous solutions in polar solvents, while they 
formed aggregates in weakly polar solvents. On the basis of data it was estimated 
that the average number of ALM molecules found in the aggregates was less than 
nine. Applying the results derived from the experiments, a MD-based model was 
proposed for the aggregates of ALM analogues, which composed of two ALM 
tetramers parallel to each other, and both of them consisted of four helical peptides 
associated in a ‘head-to-tail’ fashion. Additionally it was concluded that the ‘head-to-
tail’ arrangement observed in the aggregates was in agreement with the packing of 
peptides detected in the crystal structure of [TOAC16,Glu(OMe)7,18,19] ALM F50/5 
[39]. In a subsequent study, for three spin-labeled ALM analogues mentioned above, 
the supramolecular structures of self-assembled peptides were examined by Milov et 
al. [59] in their membrane-bound states using PELDOR and Electron Spin Echo 
Envelope Modulation (ESEEM) spectroscopies, as well as molecular modeling 
methods. Based on the data derived from PELDOR measurements, distance 
distribution functions were obtained with regard to the intermolecular distances 
calculated between the TOAC residues of aggregated peptides. Nevertheless, the 
number of ALM analogues forming the aggregates was determined, and it was 
estimated that the aggregates composed of ca. 4 peptides. Applying the ESEEM 
experiments, the penetration depths and the water accessibility were estimated, 
concerning the various spin-labeled positions. Additionally, a molecular modeling 
study was performed using distance restraints derived from the intermolecular 
distances between the TOAC residues, in order to investigate the interactions 
between the helices. This model of supramolecular ALM tetramer consisted of four 
molecules packing together in a parallel fashion, which were characterized with a 
slightly tilted α-helical conformation. On the basis of geometrical data, a penknife 
model was suggested, in which two peptides were aligned parallel to each other, 
while the arrangement of two other peptides could be characterized by an angle. 
Thogersen et al. [45] carried out MD simulations combining CG and all-atom 
(AA) MD calculations to comprehensively study the processes with regard to the 
peptide aggregation as well as to the pore formation for the ALM molecules in 
hydrated DMPC lipid bilayer. Based on the CG simulations it was observed that the 
peptides aggregated spontaneously in the lipid bilayer, and it was found that these 
aggregates did not compose of a specific number of molecules. Nevertheless, the 
individual ALM peptides adopted distinct structures with respect to the lipid bilayer, 
such as surface-bound and membrane-spanning states, and the helix axis was 
orthogonal for the former conformation while it was parallel for the latter one, 
relative to the normal of membrane. In addition to the aggregation mentioned above, 
during the CG calculations, transitions were also detected between the surface-bound 
and the membrane-spanning states of molecules. On the basis of subsequent AA 
simulation it was observed that water pores were formed across the lipid bilayer, and 
the membrane leaked water molecules around the ALM aggregates. Furthermore, 
this AA calculation led to the observations that not only the form of clusters differed 
from the model suggested previously, in which the α-helices formed a symmetric 
channel, but significant deviations from the perfect α-helical structure were detected 
also for the structure of individual ALM molecules. Beside the afore-mentioned MD 
simulations, solid-state NMR measurement was carried out, and the results supported 
the conclusion obtained by the MD calculations, i.e. that the ALM peptides adopted a 
diverse set of conformations in the lipid bilayer. 
3.4. Theoretical Studies. Zhan and Lazaridis [60] performed MD simulations 
on ALM applying an implicit membrane model with membrane dipole potential in 
order to investigate the interactions between ALM and a zwitterionic bilayer. In the 
course of this theoretical study, the effects of membrane dipole potential produced on 
the orientation and the binding energy of peptides were determined. Starting either 
from parallel or from perpendicular orientation of ALM, with respect to the 
membrane plane, the peptides adopted certain tilt angles during the MD calculations. 
Additionally, a decreasing tendency was observed for the binding affinity of ALM as 
a function of the increasing dipole potential. Based on the results it could be 
concluded that not only the peptide orientation in the membrane, but also the binding 
energy of peptides could be affected by the dipole potential. 
MD simulations were carried out by Mihajlovic and Lazaridis [61] on ALM 
monomers and oligomers inserted into two types of preformed pores (toroidal and 
cylindrical) to examine their preference for the different pore shapes. This study led 
to the observations that at the end of simulations an ALM hexamer preserved the 
starting cylindrical pore if the Gln7 residues were located within the pore, however, 
the pore was found to be closed if the afore-mentioned Gln amino acids were not 
oriented towards the pore interior. These findings were in agreement with the 
prevailing view that ALM forms channel according to the most widely accepted 
“barrel-stave” model. On the basis of MD simulations it was deduced that the 
secondary structure of peptides was more stable for the ALM hexamer embedded 
into a cylindrical pore, as compared to that observed for the ALM tetramer 
embedded into a toroidal pore. In a subsequent study, MD simulations were 
performed by Mihajlovic and Lazaridis [62] on an ALM analogue in which the Gln7 
was replaced by Lys (ALM Q7K, Table 1), in order to study the formation of pores 
by this peptide, as well as to examine how the charged residues affected the pore 
formation. The same simulation strategy was applied in the course of these MD 
calculations as previously for ALM [61], and the peptides were inserted into a 
preformed cylindrical pore. The results of earlier work indicated that the ALM 
hexamer showed a preference for the cylindrical pores over the toroidal pores [61], 
however, this subsequent MD study revealed that the ALM Q7K hexamer formed 
semitoroidal pores. These observations suggested that the charged residues located in 
the N-terminal part of peptides played an important role in the formation of toroidal 
pores. Although the configuration of pores formed by ALM Q7K analogue differed 
from that observed previously for ALM [61], regarding the transmembrane 
orientations of peptides, the helicity of ALM Q7K was found to be comparable to 
that calculated for ALM. In a further study, MD simulations were carried out by 
Mihajlovic and Lazaridis [63], applying an implicit membrane model in order to 
investigate the binding of ALM to the flat membrane, as well as to the pores with 
different shapes. Based on the MD trajectories, effective binding energies of ALM 
were calculated either for its adsorbed state on flat membrane, or for its inserted 
states in the cylindrical and toroidal pores. The results indicated that the binding 
energy of ALM was more favorable in the case of pores as compared to that 
calculated in the case of flat membrane. Nevertheless, these energies revealed a 
similar binding of ALM to the cylindrical and toroidal pores, indicating that ALM 
did not show a preference for one of afore-mentioned two types of pores. An 
additional finding of this study was that the effective binding energies of different 
AMPs could be correlated with their hemolytic activities. 
 
4. Recent Results about the Biological Activities of Alamethicin. − Data 
about the biological activities of ALM published since the appearence of the review 
by Leitgeb et al. [1] are summarized in Table 2. 
4.1. Antimicrobial Activities of Alamethicin. As summarized by Leitgeb et al. 
[1], ALM was previously shown to be effective against fungi (Blastomyces 
dermatitidis, Hormodendrum compactum, Histoplasma capsulatum, Trichophyton 
mentagrophytes, Coccidioides immitis, Yarrowia lipolytica and Saccharomyces 
cerevisiae), mollicute parasites of humans, animals and plants (Acholeplasma, 
Mycoplasma and Spiroplasma species) and Gram-positive bacteria (e.g. 
Streptococcus, Staphylococcus, Bacillus, Nocardia, Bacillus, Corynebacterium 
species and anaerobic Gram-positive rumen bacteria), but – except from 
Sinorhizobium meliloti – ineffective against most of the Gram-negative bacteria 
tested so far, as the outer membrane lipopolysaccharides are probably forming a 
strong diffusion barrier against peptaibols. 
Fassi Fehri et al. [64] studied the activities of AMPs including ALM against 
Mycoplasma pulmonis, the agent of murine respiratory mycoplasmosis. The authors 
found that ALM displayed a minimal inhibitory concentration (MIC) of 6.25 µM and 
demonstrated its synergy with enrofloxacin. Thippeswamy et al. [65] studied the 
development of ALM resistance in Staphylococcus aureus, Enterococcus faecalis 
and Bacillus cereus strains by studying biomimetic membranes prepared from total 
cellular lipid extracts of wild type and ALM resistant bacteria. IC50 concentrations of 
the wild type S. aureus, E. faecalis and B. cereus strains were 5.5, 3.25 and 2.0 µg/ml, 
while resistant variants had IC50 values of 29.0, 17.0 and 9.5 µg/ml, respectively. As 
revealed by phospholipid profile analysis, the ratio of amino-group containing 
phospholipids to amino-group lacking ones increased in resistant variants of S. 
aureus and B. cereus but decreased in resistant variants of E. faecalis relative to the 
wild type strains. Linoleic acid could be detected only in resistant B. cereus. 
Acquisition of resistance to ALM was accompanied by a decrease in ALM insertion 
in the biomimetic membrane as well as changes in membrane fluidity and surface 
charge. Mehla and Sood [66] selected and characterized variants of E. faecalis that 
are resistant to different doses of ALM in order to further study the mechanisms of 
ALM resistance. The development of dose dependent resistance could be observed. 
The authors suggested that the formation of bacterial cell aggregates – which was 
observed in resistant cells – could be the primary resistance mechanism, as the cell 
surface exposed to ALM is smaller in aggregated cells. The increased membrane 
rigidity due to altered fatty acids in the case of ALM resistant variants was correlated 
with limited membrane penetration by ALM. Ayers et al. [67] examined the 
antibacterial activities of peptaibols including ALM F50 and ALM II from two 
unidentified fungi of the order Hypocreales against S. aureus and methicillin-
resistant S. aureus (MRSA). MIC values of ALM F50 and ALM II were 35 and 12 
µg /ml, respectively towards S. aureus, while 140 and 23 µg /ml, respectively 
towards MRSA. 
During a study on the induction of a non-specific permeability transition in 
mitochondria of the yeasts Yarrowia lipolytica and Dipodascus (Endomyces) 
magnusii, Kovaleva et al. [68] reported that ALM induced large-amplitude swelling 
of mitochondria and the formation of 1 nm channels in mitochondrial membranes 
permeable to divalent cations and low-molecular weight compounds. Kuharczyk et al. 
[69] studied the pathogenesis of human mtDNA mutations using a S. cerevisiae 
model where they used ALM to permeabilize mitochondria. 
A recent study shed light on the antiprotozoan activity of ALM. Ishiyama et al. 
[70] performed a wide-scale screen for antitrypanosomal compounds. Besides 
leucinostatin (A and B) and tsushimycin, ALM I was also identified as a potential 
trypanocidal compound as it showed antitrypanosomal activities both in vitro and in 
vivo. ALM I showed a potent impact against the examined T. brucei brucei strain 
GUTat 3.1 and T. brucei rhodesiense strain STIB900. In order to be able to evaluate 
both antitrypanosomal and cytotoxic activity, the authors introduced a selectivity 
index (SI: IC50 of cytotoxicity divided by IC50 of antitrypanosomal activity). 
Similarly to the other two peptides tested, ALM had a higher and lower SI than 
suramin in the case of the examined T. b. brucei and T. b. rhodesiense strain, 
respectively. Unlike leucinostatin B at 1.0 mg/kg×4 and tsushimycin at 50 mg/kg×4, 
ALM I did not achieve a cure at a dose of 3.0 mg/kg×4 in the T. b. brucei S427 acute 
mouse model, however, it extended the mean of survival days: ALM-treated animals 
survived approximately threefold longer than the untreated controls. The mode of 
action of ALM and the two other tested peptide antibiotics was suggested to be via 
interaction with the membrane-lipid layer of trypanosomes [70]. 
4.2. Effects of Alamethicin on Plants. ALM effects on plants already known 
before the publication of the review by Leitgeb et al. [1] include emission of 
methylsalicylate as well as induction of benzoic acid and salicylic acid in 
Arabidopsis thaliana, emission of volatiles (methyl salicylate, 4,8-dimethylnona-
1,3,7-triene, 4,8,12-trimethyltrideca-1,3,7,11-tetraene) and upregulation of salicylate 
and jasmonate biosynthesis in lima bean (Phaseolus lunatus), induction of terpene 
synthase expression in Lotus japonicus, elicitation of tendril coiling in pea (Pisum 
sativum), bryony (Bryonia dioica) and Lathyrus spp., as well as permeabilization of 
plasma and mitochondrial membranes and causing cell death at high concentrations 
in the case of tobacco (Nicotiana tabacum) [1]. 
In the study of Lühring et al. [71], the tonoplast of the giant green alga Chara 
corallina proved to be a simple but adequate membrane to explore the formation of 
new membrane pores by exogenously applied ALM: the first Cs+-conducting pores 
could be recorded within about 30 s of ALM administration at a concentration of 11 
µM. 
Juszczuk et al. [72] measured the respiratory activities of isolated wild type and 
deletion mutant mitochondria of cucumber (Cucumis sativus) in the presence and 
absence of ALM. Addition of ALM increased oxygen consumption with NADH both 
in the leaf and root mitochondria of the wild type. In leaf mitochondria, the addition 
of ALM during malate oxidation and complete access of substrates and cofactors 
increased the respiration rates by ∼40% in both the wild type and the mutant MSC16 
(which is characterized by slower growth and leaf spots of mosaic type). In root 
mitochondria, the increase in malate oxidation in the presence of ALM was 60 and 
70% in wild type and MSC16 mitochondria, respectively [72]. 
Rippa et al. [73] examined the death process in A. thaliana treated with ALM. 
ALM triggered rapid death with 100% mortality at a concentration of 50 µM: the 
rigidity of the leaves was lost and they became soft already 1 h after the treatment. 
This effect of ALM proved to be associated with the dramatic loss of intact RNA due 
to the degradation of 18S and 25S ribosomal RNA and in the inhibition of protein 
synthesis. Based on their results, the authors suggested that a specific stimulus 
activates RNases which leads to the cleavage of cytosolic and chloroplastic rRNA 
molecules at specific sites. Experiments conducted with ALM-dUL, a synthetic 
ALM analogue in which all Aib residues are replaced by leucine moieties, showed 
that the Aib residues are essential for the induction of rRNA cleavage and triggering 
plant death [73]. In a subsequent study [74], the cell death induced in A. thaliana cell 
cultures by high concentrations of ALM was found to be associated with cell 
shrinkage and DNA fragmentation which are characteristic to programmed cell death, 
while the lesion development in mature plants induced by lower ALM-
concentrations was characterized as a hypersensitive-like response with callose 
deposition, production of reactive oxygen species (ROS) and phenolic compounds as 
well as the transcription of defense-related genes. The authors compared the effect of 
ALM with melittin, a natural antimicrobial from the venom of the bee Apis mellifera 
as well as with the peptaibol ampullosporin A and synthetic analogues of the 
peptaibols cervinin and trichogin, and found that the response amplitude in A. 
thaliana increased with the peptaibol’s membrane permeabilization ability and was 
strongly associated with α-aminoisobutyric acid content. 
In the case of A. thaliana leaves, the transcription of geranyllinalool synthase 
was found to be upregulated after treatment with ALM, resulting in induced emission 
of (E,E)-geranyllinalool and its suggested degradation product 4,8,12-
trimethyltrideca-1,3,7,11-tetraene, which is emitted also after herbivore attack and is 
assumed to play a role in attracting predators or parasitoids of herbivores [75]. 
Bruinsma et al. [76] used ALM to induce an early step of plant defence signal 
transduction in Brussels sprouts plants (Brassica oleracea var. gemmifera), and to 
compare its effect with that of jasmonic acid (affecting a late step of plant defence) 
on volatile emission and on the behavioural response of females of the white 
butterfly parasitoid wasp Cotesia glomerata to volatiles. The four major volatile 
components emitted were the monoterpenes limonene, 1,8-cineole, sabinene and α-
thujene. C. glomerata was attracted to plants treated with ALM in a dose-dependent 
manner. ALM proved to be a 20 times more potent inducer of indirect plant defence 
than jasmonic acid [76]. 
In order to enable the in situ investigation of callose synthesis regulation, 
Aidemark et al. [77] applied ALM for the permeabilization of A. thaliana and 
tobacco cell suspensions. ALM was shown to permeabilize the plasma membrane, 
the envelope of plastids and the inner mitochondrial membrane, making the studying 
of the regulation of plasma membrane-bound callose synthesis possible. Plastids 
were permeabilized at somewhat higher ALM concentrations than the plasma 
membrane. The results of this study suggested that ALM-induced permeabilization 
mimics the signal for the induction of a defense response against plasmodesmal 
leakage, which leads to the closing of plasmodesmata, assisted by callose formation 
being induced by the elevated Ca2+. 
In a subsequent study, Aidemark et al. [78] pre-treated tobacco (Nicotiana 
tabacum L. cv Bright Yellow-2) cells with elicitors of defence responses in order to 
study whether this affects permeabilization by ALM. It turned out from oxygen 
consumption experiments that added Trichoderma cellulase induced cellular 
resistance to ALM, which was independent of novel protein synthesis and proved to 
be associated with changes in the plasma membrane lipid composition of tobacco 
cells: isolated plasma membranes from cellulase-pretreated tobacco cells contained 
less negatively charged phospholipids than the control membranes and could be 
characterized with higher ratios of membrane lipid fatty acid to protein and sterol 
[78]. 
Maischak et al. [79] tested ALM application-elicited electrical signals on 
lima bean (P. lunatus) and barley (Hordeum vulgare) using the non-invasive method 
with microelectrodes placed in the apoplasm of the sub-stomatal cavities of open 
stomata. The authors demonstrated that both local and long-distance electrical signals 
can be induced by treatment with ALM. In the case of lima bean, a 40 mV 
depolarization was induced and detected at a distance of 5 cm on the same leaf upon 
a 5 nM ALM stimulus. In the case of barley, the application of 25 nM ALM on one 
leaf resulted in a 45 mV depolarization response on a different leaf at a distance of 
25 cm, indicating that ALM induced a systemic electrical response [79]. 
In the study of Ng et al. [80], both miR163 – a recently evolved miRNA in A. 
thaliana – and its target genes PXMT1 and FAMT – encoding a family of small 
molecule methyltransferases involved in secondary metabolite biosynthetic pathways 
– proved to be induced by ALM treatments, suggesting their potential roles in 
defense response pathways. 
In a recent study on the spikemoss Selaginella moellendorfii, Li et al. [81] found 
that while untreated plants did not emit terpenes, a number of monoterpenes 
including linalool and sesquiterpenes (e.g. β-elemene, germacrene D, β-
sesquiphellandrene, and nerolidol) could be detected from plants treated with ALM 
in order to mimick pathogen infection. Furthermore, some S. moellendorfii microbial 
terpene synthase-like genes were shown to be induced by ALM treatment, suggesting 
that the emission of terpenoids may have a role in plant defense. 
4.3. Effects of Alamethicin on Animal Cells. Regarding the effects on 
arthropods, ALM was found to induce tissue damage in Culex pipiens mosquito 
larvae, induced rapid efflux of intracellular K+ through the plasma membrane of the 
fall armyworm Spodoptera frugiperda and the spruce budworm Choristoneura 
fumiferana, and proved to be toxic to the brine shrimp Artemia salina and the water 
flea Daphnia magna [1]. In a recent study, ALM was shown to cause maximal 
swelling of the mitochondria in the case of brown shrimp (Crangon crangon) and 
common prawn (Palaemon serratus) [82]. 
Poirier et al. [83] performed embryotoxicity bioassays with oysters 
(Crassostrea gigas) in order to assess the acute toxicity of ALM as a reference 
compound and different groups of peptaibols produced by a marine strain of T. 
longibrachiatum isolated from mussels (Mytilus edulis). ALM showed 22±4% 
abnormalities (segmented eggs, normal or malformed embryos, D-larvae with 
convex hinge, indented shell margins, incomplete shell or protruded mantle) at the 
lowest tested concentration of 0.5 nM, which increased to 64±38% at 23 nM. A 
further increase in the concentration did not increase the ratio of abnormalities. An 
EC50 value of 31±3 nM could be determined for the ALM mixture (Sigma–Aldrich, 
A4665) consisting of analogues F50/5, F50/6a, F50/7 and F50/8b [83]. 
During the examination of the antihelminthic activities of peptaibols 
including ALM F50 against Barber's pole worm (Haemonchus contortus), the IC50 
values (determined as the concentration reducing cellular proliferation by 50% 
relative to untreated controls following 72 h of continuous exposure) proved to be 
0.2 µg/ml for ALM F50 [67]. 
The review of Leitgeb et al. [1] discussed previous results about the effects of 
ALM on mammalian cells, including oral toxicity towards mice at high 
concentrations, cytolytic activity towards Ehrlich ascite tumor cells, rat peritoneal 
mast cells as well as bovine and mouse lymphocytes, hemolytic activity towards 
human erythrocytes, induction of spontaneous permeabilization of plasma membrane 
to ATP in mouse lymphocytes, motility inhibition, plasma-membrane damage, 
depletion of intracellular esterases and mitochondrial depolarization in boar 
spermatozoa, membrane-modifying activity and dissipation of mitochondrial 
membrane potential in human lung epithelial carcinoma cells, feline fetus lung cells 
and murine neuroblastoma cells, catecholamine release in cat adrenal glands as well 
as permeabilization of cells to Ca2+, Mn2+, and Ni2+ in bovine adrenal chromaffin 
cells [1].  
Ayers et al. [67] examined the cytotoxicity of peptaibols including ALM F50 
and ALM II from two unidentified fungi of the order Hypocreales towards human 
breast carcinoma (MCF-7), human large cell lung carcinoma (H460), human 
astrocytoma (SF-268), fibroblast (IMR90) and human melanoma (MDA-MB-435) 
cell lines, and determined the IC50 values (concentrations required to reduce cellular 
proliferation by 50% relative to untreated controls following 72 h of continuous 
exposure) of 2.2, 3.4, 2.3, 4.8 and 8.9 µM for ALM F50 and 1.1, 1.6, 1.7, 4.0 and 6.2 
µM for ALM II, respectively. 
ALM can be used to permeabilize membranes of different mammalian cell 
types. It is frequently used to permeabilize the cytoplasma membrane [84] and 
membranes of the endoplasmatic reticulum [84a], vesicles [85] or mitochondria [86]. 
Weidema et al. [84b] studied the permeabilization of the cell membrane of neuron-
like rat pheochromocytoma cells (PC12) by zervamicin IIB – a  16-mer peptaibol 
capable of producing voltage-dependent conductances in artificial membranes – with 
the whole-cell patch-clamp technique and compared it with the permeabilization of 
ALM F50/5 and the cation channel-forming peptide antibiotic gramicidin D. The 
permeabilizing effects of ALM and zervamicin IIB proved to be different from those 
of gramicidin D, they were increased by cis-positive membrane potentials in the 
physiological range and may include calcium entry into the PC12 cell. Doleh and 
Romani [87] applied ALM to enhance permeability of the endoplasmic reticulum 
(ER) membrane in hepatocytes of male Sprague–Dawley rats to glucose-6-phosphate 
bypassing the transport mechanism, and found that the addition of ALM to the 
incubation system results in a marked decrease in the Mg2+ concentration present 
within the ER lumen. ALM is also routinely used to form pores in liver microsomes 
[88] to activate UDP-glucuronosyltransferases and predict glucuronidation clearance 
for drugs. 
During the past five years, ALM (Sigma–Aldrich, A4665) has been used as a 
reference compound during the description of the biological activities of newly 
described peptaibols towards mammalian cells [89] and in studies aimed at the 
investigation of mitochondrial functions. 
Using ALM as a reference compound during the study of acrebol, a peptaibol 
isolated from the filamentous fungus Acremonium exuviarum, Andersson et al. [89a] 
found that ALM depleted boar spermatozoa from ATP and NADH at the same 
exposure concentrations (EC50 = 150 ng dry substance/ml of extended boar semen) 
which inhibited motility, and destroyed the plasma membrane permeability barrier. 
At a concentration of 500 ng/ml, ALM was found to initiate fast cell death of MIN-6 
mouse insulinoma cells observable by propidium iodide staining already after 4 h of 
incubation, and to induce a massive release of cytochrome c from the mitochondria 
of MIN-6 cells [90]. According to this study, ALM induced high amplitude swelling 
of isolated rat liver mitochondria in sucrose-mannitol-based media and liberated 
considerable amounts of cytochrome c from the mitochondria, which is a prerequisite 
of apoptosis. ALM was found to induce swelling in both isolated rat liver and non-
synaptic rat brain mitochondria, the permeabilization of the outer mitochondrial 
membrane with ALM enabled the release of apoptosis-inducing factor [91].  
ALM was used as a control for maximal cytochrome c release in the case of 
brain mitochondria of male Sprague-Dawley rats [92], mitochondria of mouse liver 
[93], human tumor cell lines [93a], dopaminergic neuronal MES cells and human 
neuroblastoma cells [94]. Similarly, Lecoeur et al. [95] used ALM as a standard of 
cytochrome c release detection in mitochondria isolated from liver, brain, and heart 
of mice. Morota et al. [96] used ALM to induce a standardized maximal swelling 
response when comparing the capacity of calcium retention in spinal cord and brain 
mitochondria of adult male Wistar rats. ALM was used as a positive control to 
demonstrate the rapid induction of mitochondrial swelling and Ca2+ release by 
Perchellet et al. [97] in the case of mitochondria isolated from mouse liver. ALM 
was also used by Konrad et al. [98] as a calibration standard causing maximal 
swelling of mitochondria. Hansson et al. [99] calculated the extent of swelling in the 
case of adult human brain and liver mitchondria as the calcium-induced decrease in 
light scattering compared to that by ALM.  
Hansson et al. [100] studied the calcium-induced generation of ROS in brain 
mitochondria of adult male Wistar rats, and found that unspecific permeabilization of 
the inner mitochondrial membrane by ALM immediately decreased the respiratory 
rate and increased the level of ROS independently of calcium, which was further 
potentiated if NAD(H) was added to the system. Kristian et al. [101] studied 
calcium-induced precipitate formation in brain mitochondria and found that the 
addition of ALM after carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone 
(FCCP) induced essentially complete liberation of intramitochondrial calcium. 
Gerencser et al. [102] labeled mitochondria of rat cortical astrocytes and neurons by 
transient transfection with plasmid vectors encoding mitochondrially targeted 
DsRed2 (mito-DsRed2). Fluorescence images revealed that after treatment with 
ALM, tubular mitochondria of primary cortical astrocytes shortened in length and 
swelled in width into large spherical structures filled with mito-DsRed2. ALM 
treatment also led to the rupture of the inner mitochondrial membrane and to the 
DsRed2-release from swollen mitochondria. ALM-evoked swelling was only half or 
less than half as extensive in neurons as in astrocytes [102]. Mirandola et al. [103] 
found that the inhibitory effect of methylmalonate (but not that of malonate) on 
succinate-supported oxygen consumption of brain mitochondria was minimized after 
nonselective permeabilization of mitochondrial membranes by ALM. 
Permeabilization of isolated rat forebrain mitochondria with ALM abolished the 
reduction of oxygen consumption elicited by ethylmalonic acid, methylmalonic acid 
and butylmalonic acid in succinate maintained respiring mitochondria [104]. Tretter 
and Adam-Vizi [105] investigated the effect of high Ca2+ load in ALM-treated 
mitochondria from the brain of male guinea-pigs, and found that the treatment did 
not alter the effect of Ca2+, the elevated H2O2 generation in response to 10 µM Ca2+ 
was unaffected in mitochondria that were made functionally incompetent by ALM 
treatment. 
Salnikov et al. [106] applied ALM for the perforation of mitochondrial 
membranes in cardiac mitochondria, as it is capable of forming giant pores through 
both mitochondrial membranes. The simple perforation of both membranes of 
isolated cardiac mitochondria with ALM at a concentration of 80 µg/ml resulted in 
swelling of the mitochondria and a significant increase in the density of 
intramitochondrial nanoparticles. To facilitate studies of pharmacological pore 
modulation of the mitochondrial permeability transition pore (a voltage-dependent, 
large-conductance channel of the inner membrane playing an important role in 
different pathophysiological conditions), Christensen et al. [107] developed an assay 
using neonatal cardiomyocytes, where ALM was used to mediate dissipation of 
mitochondrial membrane potential. In another study aimed at the identification of the 
sources of H2O2 production by rat heart mitochondria, the addition of ALM resulted 
in 3-fold stimulation of the decomposition of H2O2 by intramitochondrial catalase 
[108]. Kaasik et al. [109] used the measurement of passive force developed by 
saponin-permeabilized mouse ventricular fibres as a sensor for compression of the 
myofibrils. The authors confirmed the mitochondrial swelling effect of ALM in 
cardiomyocytes (more homogenous mitochondrial mass, sometimes without clear 
boundaries between individual mitochondria), and found that mitochondrial swelling 
induced by ALM markedly augmented mitochondrial size, resulted in drastic 
modification of nuclear shape, and that the incubation of permeabilized fibres with 
ALM significantly increased passive force. 
 
5. Conclusions. − Due to extensive research efforts in different fields of 
biosciences, the amount of information available about ALM is extensively growing 
in the literature. 
In spite of the fact that a large amount of experimental data was recorded, the 
organization of ALM pores in lipid membranes and their regulation are not 
completely understood presently and need further research activities. To help the 
examination of ALM incorporated into different lipid bilayers, a number of 
membrane-forming techniques were introduced and will be developed expectedly in 
the future, which allow the long-term investigations or high-throughput screening of 
potential ion channel peptides. The continued study of pore modulation effects and 
the electrical (conductance) features of membranes depending on the size variation of 
formed pores (or ‘defects’) also has a great importance and can enable the 
application of the lipid-ALM system in the biosensors as bionanoelectronic or 
biomechanotransductive interfaces.  
Recent X-ray diffraction, spectroscopic and theoretical studies provided new 
valuable results with regard to the structural and conformational properties of ALM 
and its analogues, as well as to the 3D structure of ALM channels. These structural 
investigations, applying several novel experimental techniques and computational 
methods, supplied more information not only about the structural and dynamic 
features of ALM peptides and their channels, but also about the interactions evolved 
between ALM peptides and a variety of lipid bilayers. On the whole, the recent 
experimental and theoretical studies led to numerous relevant observations, which 
might provide deeper insights into the mechanism of action of ALM at the molecular 
level. 
Publications of the past five years revealed further data about the antibacterial 
and antifungal activities of ALM as well as about ALM resistance in microbes. New 
data were reported about its antiprotozoan activity, details about its role in induction 
of electrical signals, defence responses and cell death in different plants, about its 
effects on further animal organisms like oysters and nematodes as well as on a series 
of different mammalian cell cultures. ALM is also more and more routinely applied 
for the permeabilization of biological membranes, furthermore, as a model 
compound of the family of peptaibols, today it is an indispensable reference 
substance in the intensively growing field of peptaibol research. Moreover, based on 
its diverse biological acivities it can be expected that further application possibilities 
of ALM itself may be suggested in the near future. 
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Table 1. ALM Analogues Due to Substitution and/or Incorporation of Certain 
Residues (variable residues are marked bold) 
 
ALM analogues Sequences Ref. 
[Glu(OMe)18,19] ALM 
F50/5a) 
Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-
Aib-Aib-Glu(OMe)-Glu(OMe)-Phol 
[49] 
[Glu(OMe)7,18,19] ALM 
F50/5 
Ac-Aib-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Glu(OMe)-
Glu(OMe)-Phol 
[49] [50] 
Fmc-[Glu(OMe)7,18,19] ALM 
F50/5b) 
Fmc-Aib-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Glu(OMe)-
Glu(OMe)-Phol 
[49] 
[Glu(OMe)7,18,19] ALM 
F50/5-Fmc 
Ac-Aib-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Glu(OMe)-
Glu(OMe)-Phol-Fmc 
[49] 
[TOAC1,Glu(OMe)7,18,19] 
ALM F50/5c) 
Ac-TOAC-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Glu(OMe)-
Glu(OMe)-Phol 
[50] [53] 
[58] [59] 
[TOAC8,Glu(OMe)7,18,19] 
ALM F50/5 
Ac-Aib-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-TOAC-Val-Aib-Gly-
[50] [58] 
[59] 
Leu-Aib-Pro-Val-Aib-Aib-
Glu(OMe)-Glu(OMe)-Phol 
[TOAC16,Glu(OMe)7,18,19] 
ALM F50/5 
Ac-Aib-Pro-Aib-Ala-Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-TOAC-Aib-Glu(OMe)-
Glu(OMe)-Phol 
[39] [50] 
[51] [58] 
[59] 
[TOAC1,16,Glu(OMe)7,18,19] 
ALM F50/5 
Ac-TOAC-Pro-Aib-Ala Aib-Ala-
Glu(OMe)-Aib-Val-Aib-Gly-Leu-
Aib-Pro-Val-TOAC-Aib-Glu(OMe)-
Glu(OMe)-Phol 
[50] [52]  
[(R)-CF3-Ala5] ALM F30/3d) Ac-Aib-Pro-Aib-Ala-((R)-CF3-Ala5)-
Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-
Pro-Val-Aib-Aib-Gln-Gln-Phol 
[54] 
[(S)-CF3-Ala5] ALM F30/3 Ac-Aib-Pro-Aib-Ala-((S)-CF3-Ala5)-
Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-
Pro-Val-Aib-Aib-Gln-Gln-Phol 
[54] 
[(R)-CF3-Ala10] ALM F30/3 Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-((R)-CF3-Ala5)-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Gln-Gln-Phol 
[54] 
[(S)-CF3-Ala10] ALM F30/3 Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-((S)-CF3-Ala5)-Gly-Leu-
Aib-Pro-Val-Aib-Aib-Gln-Gln-Phol 
[54] 
[(R)-CF3-Ala16] ALM F30/3 Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-
((R)-CF3-Ala5)-Aib-Gln-Gln-Phol 
[54] 
[(S)-CF3-Ala16] ALM F30/3 Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-
Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-
((S)-CF3-Ala5)-Aib-Gln-Gln-Phol 
[54] 
HG-ALM H2N-His-Gly-Aib-Pro-Aib-Ala-Aib-
Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-
Pro-Val-Aib-Aib-Gln-Gln-Phe-
CONH2 
[54] 
HG-[Leu]ALM H2N-His-Gly-Leu-Pro-Leu-Ala-
Leu-Ala-Gln-Leu-Val-Leu-Gly-Leu-
Leu-Pro-Val-Leu-Leu-Gln-Gln-Phe-
[54] 
CONH2 
HG-[Nva]ALMe) H2N-His-Gly-Nva-Pro-Nva-Ala-
Nva-Ala-Gln-Nva-Val-Nva-Gly-Leu-
Nva-Pro-Val-Nva-Nva-Gln-Gln-Phe-
CONH2 
[55] 
HG-[Nle]ALMf) H2N-His-Gly-Nle-Pro-Nle-Ala-Nle-
Ala-Gln-Nle-Val-Nle-Gly-Leu-Nle-
Pro-Val-Nle-Nle-Gln-Gln-Phe-
CONH2 
[55] 
ALM Q7K Ac-Aib-Pro-Aib-Ala-Aib-Ala-Lys-
Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-
Aib-Aib-Glu-Gln-Pheol 
[62] 
 
a) Ac=acetyl, Phol=phenylalaninol, Glu(OMe)=γ-methyl glutamate. b) Fmc=9H-
fluoren-9-ylacetyl. c) TOAC=2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-
carboxylic acid. d) CF3-Ala=trifluoromethylalanine. e) Nva=norvaline. f) 
Nle=norleucine. 
 
 
Table 2. Biological Effects of ALM Reported since the Publication of the Review by 
Leitgeb et al. [1] 
 
Target Effect of ALM Ref. 
Bacteria   
Enterococcus faecalis inhibition, development of 
resistance 
[65] [66] 
Staphylococcus aureus 
 
 
methicillin-resistant Staphylococcus aureus 
(MRSA) 
inhibition, development of 
resistance 
inhibition 
inhibition 
[65] 
 
[67]  
[67]  
 
Bacillus cereus inhibition, development of 
resistance 
[65] 
Mycoplasma pulmonis inhibition, synergy with 
enrofloxacin 
[64] 
Fungi   
Yarrowia lipolytica, 
Dipodascus (Endomyces) magnusii 
large-amplitude swelling of 
mitochondria 
[68] 
Saccharomyces cerevisiae atp6-W136R mutant permeabilization of 
mitochondria 
[69] 
Protozoa   
T. brucei brucei, T. brucei rhodesiense antitrypanosomal and 
cytotoxic activity 
[70] 
Plants   
Chara corallina pore formation in tonoplast 
membrane 
[71] 
Cucumis sativus increased respiration rate and 
malate oxidation in leaf and 
root mitochondria 
[72] 
Arabidopsis thaliana rapid death, induction of 
rRNA cleavage 
[73] 
Arabidopsis thaliana cell shrinkage, DNA 
fragmentation and cell death 
in cell cultures by high ALM 
concentrations 
hypersensitive-like response 
(callose deposition, 
production of reactive 
oxygen intermediates and 
phenolic compounds, 
transcription of defense 
genes) by lower ALM 
concentrations 
[74] 
Arabidopsis thaliana induction of miR163 and its 
target genes 
[80] 
Arabidopsis thaliana induced emission of (E,E)-
geranyllinalool and 4,8,12-
trimethyltrideca-1,3,7,11-
tetraene 
[75] 
Brassica oleracea var. gemmifera volatile emission, attraction 
of the parasitoid wasp 
Cotesia glomerata  
[76] 
A. thaliana and Nicotiana tabacum cell 
suspensions 
permeabilization of the 
plasma membrane, the 
envelope of plastids and the 
inner mitochondrial 
membrane 
[77] 
Phaseolus lunatus 
 
Hordeum vulgare 
induction of local electrical 
signals  
induction of long-distance 
electrical signals 
[79] 
 
[79] 
Selaginella moellendorfii induction of microbial 
terpene synthase-like genes 
and the emission of mono- 
and sesquiterpenes 
[81] 
 
 
Molluscs   
Crassostrea gigas embryotoxicity [83] 
Nematodes   
Haemonchus contortus inhibition of larval motility [67]  
Arthropods   
Crangon crangon and Palaemon serratus maximal swelling of 
mitochondria 
[82] 
Mammals   
human breast carcinoma, human large cell lung cytotoxicity [67] 
carcinoma, human astrocytoma, fibroblast and 
human melanoma cell lines 
neuron-like rat pheochromocytoma cell permeabilization of the cell 
membrane 
[84b] 
rat hepatocytes enhancment of ER 
membrane permeability to 
glucose-6-phosphate, 
decreasing Mg2+ 
concentration present within 
the ER lumen 
[87] 
human liver microsomes 
 
 
 
human intestinal microsomes 
rat liver microsomes 
permeabilization of 
microsomes and activation of 
UDP-glucuronosyl-
transferases 
[88a, b, c, e, 
f, g, j, m] 
 
 
[88b, e, i, j] 
[88g, h] 
boar spermatozoa motility inhibition, depletion 
from ATP and NADH 
[89a] 
isolated rat liver mitochondria high amplitude swelling, 
liberation of considerable 
amounts of cytochrome c 
[90] 
rat spinal cord and brain mitochondria induction of maximal 
swelling response 
[96] 
mouse liver mitochondria rapid induction of swelling  [97] 
adult human brain and liver mitchondria swelling [99] 
mitochondria of rat cortical astrocytes and 
neurons 
swelling, rupture of the inner 
mitochondrial membrane 
[102] 
cardiomyocytes mitochondrial swelling, 
drastic modification of 
nuclear shape 
[109] 
cardiac mitochondria swelling, perforation of 
mitochondrial membranes, 
increase in the density of 
intramitochondrial 
nanoparticles 
[106] 
mouse insulinoma cells fast cell death, massive 
release of cytochrome c from 
mitochondria 
[90] 
rat brain cells 
 
mouse liver cells 
human tumor cell lines 
 
dopaminergic neuronal MES cells, human 
neuroblastoma cells 
mouse liver, brain and heart cells 
release of cytochrome c from 
mitochondria 
[92] 
 
[93] 
[93a] 
 
[94] 
 
[95] 
non-synaptic rat brain mitochondria permeabilization, release of 
apoptosis-inducing factor 
[91] 
rat brain mitochondria decreasing of the respiratory 
rate, increasing of the level 
[100] 
of reactive oxygene species 
brain mitochondria complete liberation of 
intramitochondrial calcium 
[101] 
neonatal cardiomyocytes dissipation of mitochondrial 
membrane potential 
[107] 
rat heart mitochondria stimulation of the 
decomposition of H2O2 by 
intramitochondrial catalase 
[108] 
 
 
